JFIFXXC    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222">!1AQ"aq2BR#34CSbrᒲ#!1"AQa# ?2M! fX*I}4,5m]=j)6J1'оZGH'''Vh[llk<%"UQK[+eӷ7]ndɺX_`ڏ01_^E'7{l&΢򋌜d-lkII%1Myj1r' yw#L>f\|&^6Vx\c=}tB0ܻS~[߉ԟNFVM̫lyǿ.$k#V՚OrDe] eT<Ѭ1rV)uVḘKL&oRfvKm#ҩ<`?vQ~YwQb!8m.NXEɜWRŖ>f#.8KWIdžI/ߜb ɓKݭ_/ώOݝ~>/7%㶺?6#\#F+I;ns+{>vÏeɻjN>K7?BriELb^fxr2iVq{FfkUGoɨŷlv c6X~ԬzSm%|7~l古WDv|;S.)7]=zMS||kpl.ʶ5=[߯|i2ݲGaJbڵ"ׇ<˹v,agS[1־+]f>!c=~Y.~fVT1'L6'鳓seO_vxWUvAN<:kd4^p N=R]qQUc0K 8 uN7-uk$F-4 uE2/}-M&=+iȕO^1'Wt,^\lZV k/̫mlVE5t ,9C~q3ٹK;)|mݱʪSjqP'/vve eA?^ޛ}[zϵJJ1nM%ޏva'W V=r}lӒ_-aVyMvc.ߧS_w]-5y8صڊdq-zf eݛ=3xF%ktLqY3,Z{^ zSZ&c "iyՐ8y_Oqa,eOD9ߑ.mWl$qi>^= 'lϙz2eYZ<dhƻ^&/Kr63g5(EG߫<2r掷\넥W( ]t.[Ok͒bDPEhN3uOkq{[^ )z! 6oEZfVMnOMEk?}SO\B-򯬺?)U*:.~/= ȫ]i._}_ƾ#Jy3KR[_ds κcWp$%rjJ]7'6d+Y4e68]Uv([OFq|Ay7W' dך$Wt%//.9zN|yb766RIzO_ep^fו_6#dy |JiI?&MUKsx9auV2IzT$MFT(~|7'x\Z=(J^ oFmI7tٗQjS:#V%2Μ/sPپTYVI_l_&PK_YY˵퓥bYEr{%gHMz8Yģedd_>y5%ѽ/ʏ7]b^]O͸'q-/Wgɯ2-棚tjKzrqk$'ZWHZK|_FąQ&mmt)`bNP5S)$[G._,&Ǭϩe&Z_v^. #_HKWYSؗ_/O?$xT,*2BMkwmy 8p5ޟԚ@15U*zi7ˏqS8JZIv8CqnMyh~Lq%vб*k|EIs@D5[g' ܊8O ɶV$Lڋ؏ob!?&?SO,ll{G'58p//^1CqNN6KkX#,Vz<.M:vѸ bdd2BJ07+kZZ^2H fv("qFI wl{oomEd1y5[uY\^ݰI/h -ٗPgDO-Ey=*p5'Vccv&]l)zz+8,qՋٮ#-K?а[gf՜̷|ܕCmɶmnkho^-/mCIZMh6Czk^OO6FWyako} nmt.8o\$:%gkIsP7__&L: .ԚW-_Hq\XBͿ-ofҪUUStږ5%-5u,HZU6VSM}:({^Of+.৹J>Rkՙu_)/q,;?sMJcjVXТ}aWr4YKgŻIOo'ql썷>WUxEsn },糹]rryWZ#mg RܢkɕQw[8VEYPw%jm$'y>w񿱨&umߏmʾEAo_"3#YȄȌm(ߊ"eƸJ)M+'MsSoɖUJiuDiy{k|:k?f9_{kn pl2ƸW\)Eyrs5Um5y7-e_ %4?"8cr6n;m,X$aߢde1= VUtj||=Xn%XV.r[W'_h6$hׄcVM2lHhW\Wz]R%6czTȩR]g⟔veq{';ԨU.i7(sׇ,lZޣKkGľeGVZ/ݓR?)4dˈb[F|n/ݗ?&л-W/[r\Fcdٌ7d̍; q^GI=:3x3s&=skr׆߁1lR3oվ sPQPܧ#̡ /%g 4߯SxmWo{>.3ʸ>W'_"z Eo瞀TLۊg&e1*k\gam4<[3MʫelzIV_ñ-yUn2Kvfk|W/[n<'j/<]kpX\ObawjQ83_߇Ml飄z_clpꏊrgr;p\/ܪM.R7Eb cUrUn)ZS鶗0VR#"]:HK[ZQZѮ9Κ%78mT{~NKa,TLTj+bqfjП: Ӌ7$O<="ݭ\ܢ#Y _VIxVy8c(+mr鸖,It93~+,U?\? 2qy.g^ų{1+',)d1lEtׄu}3E_&m)RqPK~Ihܩ"yi[{ۜï#/lږ׺e y7Sj%G4Gm19r#+f[\x= l9S] dW\$e迹Lr]ĸb?.U*g%l^N#N^9EssT+|J2(@xkizZǾ4BM68s]/}UmƵ-'g.ⓎVf]c?5cJ7wGYӤѯL~G(+pQQQKIkI,+w`*U4cߋ6B@vJŎ/~8|԰gY?r_)'/->ygSMgl\2Κ*ǭWUq6.Vv% ;s-e°d/XV{/WL F.nn;ֶexXX0Ғ]tIv